Evidence map›Paper›PMID 35940834›Full record

ArticleBMJ open2022

Reporting and transparent research practices in sports medicine and orthopaedic clinical trials: a meta-research study.

Robert Schulz, Georg Langen, Robert Prill, Michael Cassel, Tracey L Weissgerber

Abstract read
In one paragraph

Article in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Checklists, risk of bias tools, and reporting guidelines for research in orthopedics, sports medicine, and rehabilitation.Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA · 2023
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Is the future of peer review automated?BMC research notes · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Robert SchulzBIH QUEST Center for Responsible Research, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.ORCID 0000-0002-4830-309X
Georg LangenDepartment of Strength, Power and Tactical Sports, Institute for Applied Training Science, Leipzig, Germany.ORCID 0000-0003-4285-5253
Robert PrillCenter of Orthopaedics and Traumatology, Brandenburg Medical School Theodor Fontane, Neuruppin, Brandenburg, Germany.ORCID 0000-0002-4916-1206
Michael CasselDepartment of Sport and Health Sciences, University of Potsdam, Potsdam, Brandenburg, Germany.ORCID 0000-0002-6947-4517
Tracey L WeissgerberBIH QUEST Center for Responsible Research, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany tracey.weissgerber@bih-charite.de.ORCID 0000-0002-7490-2600

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTransparent reporting of clinical trials is essential to assess the risk of bias and translate research findings into clinical practice. While existing studies have shown that deficiencies are common, detailed empirical and field-specific data are scarce. Therefore, this study aimed to examine current clinical trial reporting and transparent research practices in sports medicine and orthopaedics.

settingExploratory meta-research study on reporting quality and transparent research practices in orthopaedics and sports medicine clinical trials.

participantsThe sample included clinical trials published in the top 25% of sports medicine and orthopaedics journals over 9 months. PRIMARY AND SECONDARY OUTCOME MEASURES: Two independent reviewers assessed pre-registration, open data and criteria related to scientific rigour, like randomisation, blinding, and sample size calculations, as well as the study sample, and data analysis.

resultsThe sample included 163 clinical trials from 27 journals. While the majority of trials mentioned rigour criteria, essential details were often missing. Sixty per cent (95% confidence interval (CI) 53% to 68%) of trials reported sample size calculations, but only 32% (95% CI 25% to 39%) justified the expected effect size. Few trials indicated the blinding status of all main stakeholders (4%; 95% CI 1% to 7%). Only 18% (95% CI 12% to 24%) included information on randomisation type, method and concealed allocation. Most trials reported participants' sex/gender (95%; 95% CI 92% to 98%) and information on inclusion and exclusion criteria (78%; 95% CI 72% to 84%). Only 20% (95% CI 14% to 26%) of trials were pre-registered. No trials deposited data in open repositories.

conclusionsThese results will aid the sports medicine and orthopaedics community in developing tailored interventions to improve reporting. While authors typically mention blinding, randomisation and other factors, essential details are often missing. Greater acceptance of open science practices, like pre-registration and open data, is needed. As these practices have been widely encouraged, we discuss systemic interventions that may improve clinical trial reporting.

Indexed as

OrthopedicsSports MedicineHumansclinical trialsmedical education & trainingorthopaedic & trauma surgeryrehabilitation medicinesports medicinestatistics & research methods

Identifiers

PMID35940834
PMCPMC9364413

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.